{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:38:29Z","timestamp":1790811509267,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,5]],"date-time":"2018-04-05T00:00:00Z","timestamp":1522886400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005633","name":"Syd\u00e4ntutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12881-018-0574-0","type":"journal-article","created":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T14:37:12Z","timestamp":1524148632000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Clinical and molecular genetic risk determinants in adult long QT syndrome type 1 and 2 patients"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1757-7386","authenticated-orcid":false,"given":"Mikael","family":"Koponen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aki S.","family":"Havulinna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annukka","family":"Marjamaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annukka M.","family":"Tuiskula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veikko","family":"Salomaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4ivi J.","family":"Laitinen-Forsblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsi","family":"Piippo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauri","family":"Toivonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimmo","family":"Kontula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Viitasalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heikki","family":"Swan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,5]]},"reference":[{"key":"574_CR1","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/0002-8703(75)90089-7","volume":"89","author":"PJ Schwartz","year":"1975","unstructured":"Schwartz PJ, Periti M, Malliani A. The long Q-T syndrome. Am Heart J. 1975;89:378\u201390.","journal-title":"Am Heart J"},{"key":"574_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jacc.2013.04.044","volume":"62","author":"PJ Schwartz","year":"2013","unstructured":"Schwartz PJ, Ackerman MJ, George AL Jr, et al. Impact of genetics on the clinical management of channelopathies. J Am Coll Cardiol. 2013;62:169\u201380.","journal-title":"J Am Coll Cardiol"},{"key":"574_CR3","first-page":"1601","volume":"17","author":"SG Priori","year":"2015","unstructured":"Priori SG, Blomstrom-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Europace. 2015;17:1601\u201387.","journal-title":"Europace"},{"key":"574_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jacc.2010.07.038","volume":"57","author":"I Goldenberg","year":"2011","unstructured":"Goldenberg I, Horr S, Moss AJ, et al. Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals. J Am Coll Cardiol. 2011;57:51\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"574_CR5","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1161\/CIRCULATIONAHA.110.950147","volume":"122","author":"PJ Schwartz","year":"2010","unstructured":"Schwartz PJ, Spazzolini C, Priori SG, et al. Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry. Circulation. 2010;122:1272\u201382.","journal-title":"Circulation"},{"key":"574_CR6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1046\/j.1540-8167.2003.02545.x","volume":"14","author":"W Zareba","year":"2003","unstructured":"Zareba W, Moss AJ, Daubert JP, et al. Implantable cardioverter defibrillator in high-risk long QT syndrome patients. J Cardiovasc Electrophysiol. 2003;14:337\u201341.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"574_CR7","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1056\/NEJMoa022147","volume":"348","author":"SG Priori","year":"2003","unstructured":"Priori SG, Schwartz PJ, Napolitano C, et al. Risk stratification in the long-QT syndrome. N Engl J Med. 2003;348:1866\u201374.","journal-title":"N Engl J Med"},{"key":"574_CR8","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1056\/NEJM199810013391404","volume":"339","author":"W Zareba","year":"1998","unstructured":"Zareba W, Moss AJ, Schwartz PJ, et al. Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med. 1998;339:960\u20135.","journal-title":"N Engl J Med"},{"key":"574_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1161\/01.CIR.103.1.89","volume":"103","author":"PJ Schwartz","year":"2001","unstructured":"Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 2001;103:89\u201395.","journal-title":"Circulation"},{"key":"574_CR10","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.hrthm.2011.03.049","volume":"8","author":"D Migdalovich","year":"2011","unstructured":"Migdalovich D, Moss AJ, Lopes CM, et al. Mutation and gender-specific risk in type 2 long QT syndrome: implications for risk stratification for life-threatening cardiac events in patients with long QT syndrome. Heart Rhythm. 2011;8:1537\u201343.","journal-title":"Heart Rhythm"},{"key":"574_CR11","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.hrthm.2012.01.020","volume":"9","author":"J Costa","year":"2012","unstructured":"Costa J, Lopes CM, Barsheshet A, et al. Combined assessment of sex- and mutation-specific information for risk stratification in type 1 long QT syndrome. Heart Rhythm. 2012;9:892\u20138.","journal-title":"Heart Rhythm"},{"key":"574_CR12","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.amjcard.2009.08.676","volume":"105","author":"JF Liu","year":"2010","unstructured":"Liu JF, Moss AJ, Jons C, et al. Mutation-specific risk in two genetic forms of type 3 long QT syndrome. Am J Cardiol. 2010;105:210\u20133.","journal-title":"Am J Cardiol"},{"key":"574_CR13","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1161\/CIRCULATIONAHA.107.726950","volume":"116","author":"L Crotti","year":"2007","unstructured":"Crotti L, Spazzolini C, Schwartz PJ, et al. The common long-QT syndrome mutation KCNQ1\/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification. Circulation. 2007;116:2366\u201375.","journal-title":"Circulation"},{"key":"574_CR14","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1161\/CIRCEP.114.002654","volume":"8","author":"M Koponen","year":"2015","unstructured":"Koponen M, Marjamaa A, Hiippala A, et al. Follow-Up of 316 Molecularly Defined Pediatric Long-QT Syndrome Patients: Clinical Course, Treatments, and Side Effects. Circ Arrhythm Electrophysiol. 2015;8:815\u201323.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"574_CR15","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1253\/circj.CJ-15-0342","volume":"79","author":"H Itoh","year":"2015","unstructured":"Itoh H, Dochi K, Shimizu W, et al. A Common Mutation of Long QT Syndrome Type 1 in Japan. Circ J. 2015;79:2026\u201330.","journal-title":"Circ J"},{"key":"574_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1471-2261-12-95","volume":"12","author":"EL Stattin","year":"2012","unstructured":"Stattin EL, Bostrom IM, Winbo A, et al. Founder mutations characterise the mutation panorama in 200 Swedish index cases referred for Long QT syndrome genetic testing. BMC Cardiovasc Disord. 2012;12:95\u20132261. 12-95","journal-title":"BMC Cardiovasc Disord"},{"key":"574_CR17","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1001\/jama.292.11.1341","volume":"292","author":"SG Priori","year":"2004","unstructured":"Priori SG, Napolitano C, Schwartz PJ, et al. Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. JAMA. 2004;292:1341\u20134.","journal-title":"JAMA"},{"key":"574_CR18","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jacc.2006.08.057","volume":"49","author":"AJ Sauer","year":"2007","unstructured":"Sauer AJ, Moss AJ, McNitt S, et al. Long QT syndrome in adults. J Am Coll Cardiol. 2007;49:329\u201337.","journal-title":"J Am Coll Cardiol"},{"key":"574_CR19","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1540-8167.2010.01737.x","volume":"21","author":"I Goldenberg","year":"2010","unstructured":"Goldenberg I, Bradley J, Moss A, et al. Beta-blocker efficacy in high-risk patients with the congenital long-QT syndrome types 1 and 2: implications for patient management. J Cardiovasc Electrophysiol. 2010;21:893\u2013901.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"Suppl 1","key":"574_CR20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/17431380410032689","volume":"36","author":"H Fodstad","year":"2004","unstructured":"Fodstad H, Swan H, Laitinen P, et al. Four potassium channel mutations account for 73% of the genetic spectrum underlying long-QT syndrome (LQTS) and provide evidence for a strong founder effect in Finland. Ann Med. 2004;36(Suppl 1):53\u201363.","journal-title":"Ann Med"},{"key":"574_CR21","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1080\/07853890600756065","volume":"38","author":"H Fodstad","year":"2006","unstructured":"Fodstad H, Bendahhou S, Rougier JS, et al. Molecular characterization of two founder mutations causing long QT syndrome and identification of compound heterozygous patients. Ann Med. 2006;38:294\u2013304.","journal-title":"Ann Med"},{"key":"574_CR22","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/j.jacc.2009.08.028","volume":"54","author":"W Shimizu","year":"2009","unstructured":"Shimizu W, Moss AJ, Wilde AA, et al. Genotype-phenotype aspects of type 2 long QT syndrome. J Am Coll Cardiol. 2009;54:2052\u201362.","journal-title":"J Am Coll Cardiol"},{"key":"574_CR23","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1161\/CIRCGENETICS.111.960179","volume":"4","author":"A Barsheshet","year":"2011","unstructured":"Barsheshet A, Moss AJ, McNitt S, et al. Risk of syncope in family members who are genotype-negative for a family-associated long-QT syndrome mutation. Circ Cardiovasc Genet. 2011;4:491\u20139.","journal-title":"Circ Cardiovasc Genet"},{"key":"574_CR24","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1161\/CIRCULATIONAHA.106.665406","volume":"115","author":"AJ Moss","year":"2007","unstructured":"Moss AJ, Shimizu W, Wilde AA, et al. Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation. 2007;115:2481\u20139.","journal-title":"Circulation"},{"key":"574_CR25","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1016\/S0735-1097(00)00636-7","volume":"35","author":"K Piippo","year":"2000","unstructured":"Piippo K, Laitinen P, Swan H, et al. Homozygosity for a HERG potassium channel mutation causes a severe form of long QT syndrome: identification of an apparent founder mutation in the Finns. J Am Coll Cardiol. 2000;35:1919\u201325.","journal-title":"J Am Coll Cardiol"},{"key":"574_CR26","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S0735-1097(99)00255-7","volume":"34","author":"H Swan","year":"1999","unstructured":"Swan H, Viitasalo M, Piippo K, et al. Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects. J Am Coll Cardiol. 1999;34:823\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"574_CR27","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1093\/hmg\/6.11.1943","volume":"11","author":"B Wollnik","year":"1997","unstructured":"Wollnik B, Schroeder BC, Kubisch C, et al. Pathophysiological mechanisms of dominant and recessive KVLQT1 K+ channel mutations found in inherited cardiac arrhythmias. Hum Mol Genet. 1997;11:1943\u20139.","journal-title":"Hum Mol Genet"},{"key":"574_CR28","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/1098-1004(200006)15:6<580::AID-HUMU16>3.0.CO;2-0","volume":"15","author":"P Laitinen","year":"2000","unstructured":"Laitinen P, Fodstad H, Piippo K, et al. Survey of the coding region of the HERG gene in long QT syndrome reveals six novel mutations and an amino acid polymorphism with possible phenotypic effects. Hum Mutat. 2000;15:580\u20131.","journal-title":"Hum Mutat"},{"key":"574_CR29","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.jacc.2010.10.025","volume":"57","author":"JF Liu","year":"2011","unstructured":"Liu JF, Jons C, Moss AJ, et al. Risk factors for recurrent syncope and subsequent fatal or near-fatal events in children and adolescents with long QT syndrome. J Am Coll Cardiol. 2011;57:941\u201350.","journal-title":"J Am Coll Cardiol"},{"key":"574_CR30","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1161\/CIRCULATIONAHA.108.772533","volume":"119","author":"GM Vincent","year":"2009","unstructured":"Vincent GM, Schwartz PJ, Denjoy I, et al. High efficacy of beta-blockers in long-QT syndrome type 1: contribution of noncompliance and QT-prolonging drugs to the occurrence of beta-blocker treatment \u201cfailures\u201d. Circulation. 2009;119:215\u201321.","journal-title":"Circulation"}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-018-0574-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12881-018-0574-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-018-0574-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T04:42:42Z","timestamp":1720240962000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/s12881-018-0574-0"}},"subtitle":["Koponen et al. Follow-up of adult LQTS patients"],"short-title":[],"issued":{"date-parts":[[2018,4,5]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["574"],"URL":"https:\/\/doi.org\/10.1186\/s12881-018-0574-0","relation":{},"ISSN":["1471-2350"],"issn-type":[{"value":"1471-2350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,5]]},"assertion":[{"value":"23 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Participants signed an informed consent. The Ministry of Social Affairs and Health consented for the participation of the deceased subjects. The study was approved by the Ethical Review Committee of Helsinki University Central Hospital.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"56"}}